Predicting APL lethal bleeding in the ATRA era

被引：10

作者：

Falanga, Anna ^{[1
]}

机构：

[1] Hosp Papa Giovanni XXIII, Bergamo, Italy

来源：

BLOOD | 2017年 / 129卷 / 13期

关键词：

ACUTE PROMYELOCYTIC LEUKEMIA;

D O I：

10.1182/blood-2017-02-763490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this issue of Blood, Mantha and colleagues advance our understanding of risk factors for early hemorrhagic death (HD) in patients with acute promyelocytic leukemia (APL) in the all-trans retinoic acid (ATRA) era. 1 Analysis of HD risk factors in a large series of ATRA-treated patients convincingly shows that high white blood cell (WBC) count is an independent predictor of early HD. The results help to construct a profile of patients at high-risk for bleeding.

引用

页码：1739 / 1740

页数：2

共 8 条

[1] Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death [J].

Altman, Jessica K. ;

Rademaker, Alfred ;

Cull, Elizabeth ;

Weitner, Bing Bing ;

Ofran, Yishai ;

Rosenblat, Todd L. ;

Haidau, Augustin ;

Park, Jae H. ;

Ram, Sharona Lee ;

Orsini, James M., Jr. ;

Sandhu, Sonia ;

Catchatourian, Rosalind ;

Trifilio, Steven M. ;

Adel, Nelly G. ;

Frankfurt, Olga ;

Stein, Eytan M. ;

Mallios, George ;

Deblasio, Tony ;

Jurcic, Joseph G. ;

Nimer, Stephen ;

Peterson, LoAnn C. ;

Kwaan, Hau C. ;

Rowe, Jacob M. ;

Douer, Dan ;

Tallman, Martin S. .

LEUKEMIA RESEARCH, 2013, 37 (09) :1004-1009

[2] Thrombo-hemorrhagic deaths in acute promyelocytic leukemia [J].

Breccia, Massimo ;

Lo Coco, Francesco .

THROMBOSIS RESEARCH, 2014, 133 :S112-S116

[3] LOSS OF BLAST CELL PROCOAGULANT ACTIVITY AND IMPROVEMENT OF HEMOSTATIC VARIABLES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA ADMINISTERED ALL-TRANS-RETINOIC ACID [J].

FALANGA, A ;

IACOVIELLO, L ;

EVANGELISTA, V ;

BELOTTI, D ;

CONSONNI, R ;

DORAZIO, A ;

ROBBA, L ;

DONATI, MB ;

BARBUI, T .

BLOOD, 1995, 86 (03) :1072-1081

[4] The coagulopathy in acute promyelocytic leukaemia - What have we learned in the past twenty years [J].

Kwaan, Hau C. ;

Barnett, Marjorie C. ;

Cull, Elizabeth H. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2014, 27 (01) :11-18

[5] Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era [J].

Mantha, Simon ;

Goldman, Debra A. ;

Devlin, Sean M. ;

Lee, Ju-Whei ;

Zannino, Diana ;

Collins, Marnie ;

Douer, Dan ;

Iland, Harry J. ;

Litzow, Mark R. ;

Stein, Eytan M. ;

Appelbaum, Frederick R. ;

Larson, Richard A. ;

Stone, Richard ;

Powell, Bayard L. ;

Geyer, Susan ;

Laumann, Kristina ;

Rowe, Jacob M. ;

Erba, Harry ;

Coutre, Steven ;

Othus, Megan ;

Park, Jae H. ;

Wiernik, Peter H. ;

Tallman, Martin S. .

BLOOD, 2017, 129 (13) :1763-1767

[6] Bleeding and thrombosis in acute leukemia: What does the future of therapy look like? [J].

Rickles, Frederick R. ;

Falanga, Anna ;

Montesinos, Pau ;

Sanz, Miguel A. ;

Brenner, Benjamin ;

Barbui, Tiziano .

THROMBOSIS RESEARCH, 2007, 120 :S99-S106

[7] Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet [J].

Sanz, Miguel A. ;

Grimwade, David ;

Tallman, Martin S. ;

Lowenberg, Bob ;

Fenaux, Pierre ;

Estey, Elihu H. ;

Naoe, Tomoki ;

Lengfelder, Eva ;

Buechner, Thomas ;

Doehner, Hartmut ;

Burnett, Alan K. ;

Lo-Coco, Francesco .

BLOOD, 2009, 113 (09) :1875-1891

[8]

Tallman Martin S, 2005, Leuk Res, V29, P347, DOI 10.1016/j.leukres.2004.04.021

← 1 →